My regular readers and subscribers know that I am not sanguine about the prospects for the New Year. I believe the same factors that caused profits in the S&P 500 to fall year-over-year in will still be firmly in place
December 1, 2015
The best income investments are stocks that currently pay a high yield and will also grow that dividend rate over time. With new companies that come to market, it is tough to time when the first dividend increase will occur.
The Chart of the Day belongs to TherapeauticsMD (NYSEMKT:TXMD). I found the pharmaceutical stock by using Barchart to sort the Russell 3000 Indexstocks first for the highest number of new highs in the last month then again for technical buy signals of 80% or better.
Markets move higher given belief the ECB will cut interest rates Thursday. This belief trumps a host of bad economic data so far this week. Tuesday bulls ignored a substantial drop in manufacturing activity as manufacturing reports showed substantial declines.
“Think of gold as an irredeemable bond that pays no interest, but has no credit risk, where the issuer is God or the universe itself.” Charlie Morris, formerly of HSBC Global Asset Management The economic news came in badly this
<<< Read: The Lull Before The Storm—An Ideal Chance To Exit The Casino, Part 1 The danger lurking in the risk asset markets was succinctly captured by MarketWatch’s post on overnight action in Asia. The latter proved once again that the casino gamblers are
Today Synthetic Biologics (SYN) announced positive phase 2 results for prevention of a bacterial infection, known as Clostridium difficile or C. difficile. The company’s drug, known as SYN-004 is a drug that it intended to clear an IV fluid — ceftriaxone
What You’ll Learn: A brief timeline of Apple’s entry into retail A qualitative look at why Apple is such a compelling investment How Apple passes Phil Fishers 15 point checklist Fundamental comparisons with other retailers that show the true strength
Like tens of millions of Americans, I was shopping this weekend – out there in “brick and mortar” stores, no less. You know – the same retailers that are said to be heading the way of the dinosaur while they
Look for Growth in Emerging Small Cap Drug Stocks Many stocks were in the red Monday with healthcare a lagging sector down 1%. Many investors await economic data later this week and the mid-December meeting for the FED. Biotech stocks are also
